DOCSLIB.ORG

Pituitary Volume and Headache Size Is Not Everything

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pituitary Volume and Headache Size Is Not Everything ORIGINAL ARTICLE Pituitary Volume and Headache Size Is Not Everything Miles J. Levy; H. Rolf Ja¨ger, MD; Michael Powell, FRCS; Manjit S. Matharu, MRCP; Karim Meeran, MD; Peter J. Goadsby, MD, PhD, DSc, FRACP, FRCP Background: Pituitary tumors are commonly associ- ache score and pituitary volume (r=−0.32, P=.01, Spear- ated with disabling headache. The accepted mecha- man rank correlation). There was also no association be- nisms for headache are dural stretch and cavernous si- tween cavernous sinus invasion and headache. There was nus invasion. a strong association between pituitary-associated head- ache and a family history of headache (␹2=8.36, P=.004). Objective: To determine if there is a relationship be- tween pituitary tumor size and the report of headache. Conclusions: These data suggest that a pituitary tumor– associated headache may not simply be a structural prob- Design: We prospectively studied 63 patients who were lem. Other factors such as family history of headache, and initially seen with pituitary tumors. Clinical headache the endocrine activity of the tumor may be equally im- scores, pituitary tumor volume, and the extent of cav- portant determinants of headache. Elucidating these mecha- ernous sinus invasion were obtained for each patient. nisms will aid in the treatment of these patients and fur- ther our understanding of other headache syndromes. Results: The prevalence of headache was 70%. There was no positive correlation the between clinical head- Arch Neurol. 2004;61:721-725 EADACHE, A WELL-RECOG- mas,6 with approximately 12.5% report- nized feature of pitu- ing the symptom.3 Recurrence of head- itary disease, may be dis- ache after treatment may be a clinical sign abling.1,2 The reported of further disease activity.7 Somatostatin incidence of headache in analogues, such as octreotide, can have an pituitary disease ranges with tumor type immediate analgesic effect in acromegaly- H 8-10 from 33% to 72% and has been reported associated headache, in the absence of to be particularly high in prolactinomas.3 reduction in tumor size.11 This may be a bio- It has long been considered that head- chemical effect or a direct effect of activa- ache is related to tumor size and dural tion of somatostatin receptors with antino- stretch.2,4 The explanation for dural stretch ciceptive effects in the brain.12 as a cause of headache is that the expan- A variety of headache phenotypes have sion of a pituitary tumor within the sella been associated with pituitary tumors. turcica stimulates afferent fibers innervat- These include severe and intractable mi- ing the dura mater, which are certainly graine,13 trigeminal autonomic cephal- known to be pain producing.5 Involve- gias,14 such as cluster headache,15,16 short- ment of the cavernous sinus has also been lasting, unilateral neuralgiform headache From the Headache Group invoked to explain headache3 since the si- attacks with conjunctival injection and tear- (Mr Levy and Drs Matharu and nus contains the ophthalmic branch of the ing,17,18 and trigeminal neuralgia.19 In such Goadsby) and the Department trigeminal nerve and the internal carotid cases, conventional preventive and abor- of Radiology (Dr Ja¨ger), artery, both of which could generate head tive headache treatment can often prove to Institute of Neurology, pain. However, the mechanical explana- be ineffective, yet medical treatment of the Department of Neurosurgery, tion for pituitary tumor–related head- pituitary disease can completely resolve the National Hospital for ache has never been systematically ex- symptoms. For example, there are re- Neurology and Neurosurgery (Dr Powell), and the plored, although its implications for ported cases of microprolactinomas mani- Department of Endocrinology, management and understanding of the festing with severe headache that have re- Hammersmith and Charing clinical problem are profound. solved immediately with the administration Cross Hospitals Trust Headache can be a prominent feature of dopamine agonists20,21 as well as the im- (Dr Meeran), London, England. of acromegaly, even with microadeno- pressive analgesic effects of somatostatin (REPRINTED) ARCH NEUROL / VOL 61, MAY 2004 WWW.ARCHNEUROL.COM 721 ©2004 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 analogues in acromegaly.9,10 However, there are also ex- toms. A retrospective clinical headache score covering the pe- amples of significant exacerbations of headache with the riod closely related to the magnetic resonance images (MRIs) administration of dopamine-agonists in patients with pro- was calculated using the following formula: 17,22 lactinomas. (1) Headache Frequency (Days per Week) The fact that headache can be dramatically improved ϫHeadache Duration (Hours per Day) or worsened by endocrine treatments, in the absence of any ϫHeadache Severity for Peak Attack measurable change in pituitary size, suggests that pitu- (Range, 0 [no pain] to 10 [worst pain imaginable]) itary tumor–associated headache may be a biochemical- neuroendocrine problem rather than a structural one. The To validate this measurement, 22 of the 63 recruited patients aim of this study was to examine systematically the rela- (one third of the cohort) were randomly asked to complete pro- tive importance of size and cavernous sinus invasion in pi- spective headache diaries, in which an hourly headache score tuitary tumor–associated headache to test directly the hy- was documented for a 2-week period. These diaries were sent pothesis that local mechanical effects are preeminent in the to a separate headache specialist, masked to the initial evalu- causation of headache in these patients. ation and the MRI findings, who calculated a mean clinical head- ache score for each patient. The diary score and the retrospec- METHODS tive score were then compared. The presence of a family history of headache was documented in the course of the complete medi- Sixty-three patients who were initially seen with pituitary dis- cal history. ease were prospectively studied (Table 1). All patients were seen in the same unit for treatment of newly diagnosed pitu- PITUITARY VOLUME itary disease, which included both surgical and medical man- agement options. Headache, pituitary volume, and cavernous The pretreatment MRIs were performed on several different MRI sinus invasion were assessed prospectively with clinical evalu- scanners, all at 1.5 T. All examinations included coronal and ation of headache and structural data being collected by dif- sagittal T1-weighted spin-echo sequences with a maximum sec- ferent investigators in a masked fashion. tion thickness of 3 mm, before and after intravenous adminis- tration of a gadolinium-based contrast medium. All MRIs were HEADACHE assessed by the same neuroradiologist (H.R.J.). For the assess- ment of the tumor volume, it was assumed that pituitary tu- 23 Before commencement of treatment, all patients were inter- mors are ellipsoid. Using Cavalieri’s principle, pituitary tu- viewed by a trained headache fellow or specialist (M.J.L., M.S.M., mor volume was calculated after performing measurements of and P.J.G.). The clinical data collected included the presence tumor diameter in 3 orthogonal planes (Figure 1A-B), using or absence of headache and the frequency and severity of symp- the following equation: 4 ␲ (2) Volume=[ /3 (a/2·b/2·c/2)] Table 1. Clinical Headache Scores* and Tumor Activity If the tumor was large and multilobed, the tumor volume was Mean assumed to consist of separated ellipses and the sum of each No. of Headache lobe volume was calculated (Figure 1C). Tumor Subtype Patients Female, % Score Growth hormone 12 66 758 CAVERNOUS SINUS INVASION Prolactin 17 83 659 Thyrotropin 3 66 600 We assessed 3 different parameters for the assessment of pres- Craniopharyngioma 5 20 362 ence and degree of cavernous sinus involvement: Nonfunctioning adenoma 20 80 194 Corticotropin 6 100 200 1. Encasement of the internal carotid artery, distinguish- ing 4 grades: no encasement, less than 25% to 50%, more than Abbreviation: ACTH, adenocorticotrophin-stimulating hormone. 50% to 75%, and more than 75% to 100%. *Clinical headache score = headache frequency (days per 2. Crossing of the 3 lines connecting the cross sections week) ϫ headache duration (hours per day) ϫ headache severity (range, through the distal internal carotid arteries (intercarotid lines): 0 [none] to 10 [severe]). medial, median, and lateral. A B C Figure 1. Calculation of pituitary volume for a single-lobed tumor (A and B) and a multilobed tumor (C) assuming the tumor to be ellipsoid. Using 3 orthogonal 4 lines (a, b, and c), Volume=[ /3 ␲(a/2·b/2·c/2)]. (REPRINTED) ARCH NEUROL / VOL 61, MAY 2004 WWW.ARCHNEUROL.COM 722 ©2004 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/27/2021 A B MdnL C MdIL LL 2 Hypophys ICA 3 1 5 4 Figure 2. Cavernous sinus invasion. A, The venous compartments are 1, medial; 2, superior; 3, lateral; and 4, carotid sulcus. Hypophys indicates the pituitary gland; ICA, internal carotid artery. B, The intercarotid lines are medial line (MdL), median line (MdnL), and lateral line (LL). The shaded area is the pituitary gland. C, The carotid artery encasement indicates grade 1, less than 25%; grade 2, more than 25% to 50%; grade 3, more than 50% to 75%; and grade 4, more than 75% to 100%. The shaded area is the pituitary gland. Adapted from Cottier et al.24 3. Extension of the tumor into the venous compart- ments of the cavernous sinus. 1400 Based on a modification of the classification system de- 1200 scribed by Cottier et al,24 we distinguished among tumor ex- tension into the superior, lateral, and inferior venous compart- 1000 ments (Figure 2). Invasion of the medial compartment had 800 not proved significant in previous studies24 and the inferolat- eral venous and carotid sulcus compartments were grouped to- 600 gether as the inferior compartment in this study.
Load more

Recommended publications
  • Polyphagia Ellen N
    W0117-Section I (31-50).qxd 4/23/04 7:26 PM Page 124 CHAPTER • 34 Polyphagia Ellen N. Behrend olyphagia is the consumption of food in excess of and liver disease) lead to polyphagia by unknown mecha- normal caloric intake. Hunger and satiety and, conse- nisms. Secondary polyphagia can also be caused by certain P quently, feeding behavior are primarily controlled by drugs. certain regions in the central nervous system (CNS), but many factors affect the function of these areas. Thus polypha- gia can be classified as primary (i.e., a CNS abnormality) or HISTORY secondary (i.e., a systemic problem affecting the CNS). Secondary polyphagia is by far more common and usually is Any change in body weight is an important differentiating accompanied by clinical signs of the underlying disease. feature of the various causes of polyphagia (Figure 34-1). Determining whether weight gain or loss has occurred should Primary or drug-induced polyphagia typically results in weight be the first step in formulating a list of differential diagnoses gain, because nutrients are adequate and feeding is inappro- and a diagnostic plan. priately increased. Pathologic secondary polyphagia is more commonly associated with weight loss, because the nutrient supply usually does not meet physiologic demands. However, PHYSIOLOGY some causes, such as acromegaly, hypoglycemia caused by an insulinoma, sudden acquired retinal degeneration syndrome Food intake is controlled by a variety of factors, including gas- (SARDS), and hyperadrenocorticism (HAC), lead to weight trointestinal, environmental, and CNS phenomena. The CNS, gain. Physiologic polyphagia can result in weight gain (e.g., mainly the hypothalamus, controls eating behavior.The lateral pregnancy, growth) or maintenance of weight (e.g., lactation, hypothalamic nuclei represent the “feeding center”; their cold environment, increased exercise).
    [Show full text]
  • Sudden Death in Eating Disorders
    Vascular Health and Risk Management Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Sudden death in eating disorders Beatriz Jáuregui-Garrido1 Abstract: Eating disorders are usually associated with an increased risk of premature death Ignacio Jáuregui-Lobera2,3 with a wide range of rates and causes of mortality. “Sudden death” has been defined as the abrupt and unexpected occurrence of fatality for which no satisfactory explanation of the 1Department of Cardiology, University Hospital Virgen del Rocío, 2Behavioral cause can be ascertained. In many cases of sudden death, autopsies do not clarify the main Sciences Institute, 3Pablo de Olavide cause. Cardiovascular complications are usually involved in these deaths. The purpose of University, Seville, Spain this review was to report an update of the existing literature data on the main findings with respect to sudden death in eating disorders by means of a search conducted in PubMed. The most relevant conclusion of this review seems to be that the main causes of sudden death in eating disorders are those related to cardiovascular complications. The predictive value of the For personal use only. increased QT interval dispersion as a marker of sudden acute ventricular arrhythmia and death has been demonstrated. Eating disorder patients with severe cardiovascular symptoms should be hospitalized. In general, with respect to sudden death in eating disorders, some findings (eg, long-term eating disorders, chronic hypokalemia, chronically low plasma albumin, and QT intervals .600 milliseconds) must be taken into account, and it must be highlighted that during refeeding, the adverse effects of hypophosphatemia include cardiac failure.
    [Show full text]
  • Patient Information Sheet This Form Must Be Filled out with All Applicable Information Note: Patient Is Responsible for All Bills
    HAND & UPPER EXTREMITY CENTER, PA OLAYINKA OGUNRO, M.D., F.A.C.S CHARITY OGUNRO, M.D. PATIENT INFORMATION SHEET THIS FORM MUST BE FILLED OUT WITH ALL APPLICABLE INFORMATION NOTE: PATIENT IS RESPONSIBLE FOR ALL BILLS PLEASE PRINT Date: ________________________________________ Patient’s Name: _________________________________________ SS #: __________________________________ Single: __________ Married: ___________ Separated: ___________ Widow: ____________ Address: _____________________________________________ City: _____________ ST: ______ ZIP:________ Date of Birth: ___________________ Age:_________ Sex: ____________ Hm. Phone: ______________________ Weight: _________ Height: _________ Pharmacy Name & No: ________________________________________ Cell #: ___________________________ E-Mail Address: _____________________________________________ Race: White, Hispanic, Asian, African-American, Other _________________ Ethnicity:________________________ Patient’s Responsible Party’s Employer: ______________________________________________________________ Address: ______________________________________________ City: ______________ ST: _______ ZIP: _______ Position: ______________________________________________ Work Phone: _____________________________ Spouse Name: __________________________________________ Employer: _______________________________ If child, parent’s name: _______________________________________ SS #: ________________________________ Nearest Relative: ____________________________________________ Phone #: _____________________________
    [Show full text]
  • Unusual Case of Necrotizing Pneumonia Rajapriya Manickam*, Kabir Oladipo Olaniran and Raghu Loganathan
    Manickam et al. Int J Respir Pulm Med 2015, 2:2 International Journal of ISSN: 2378-3516 Respiratory and Pulmonary Medicine Case Report : Open Access Unusual Case of Necrotizing Pneumonia Rajapriya Manickam*, Kabir Oladipo Olaniran and Raghu Loganathan Division of Pulmonary and Critical care Medicine, Lincoln Medical and Mental Health Center, USA *Corresponding author: Rajapriya Manickam, Division of Pulmonary and Critical care Medicine, Lincoln Medical and Mental Health Center, Bronx, New York, USA, Tel: 917-375-5626; E-mail: [email protected] Abstract Coccidioidomycosis is caused by inhalation of Coccidoides spores which is endemic in south western parts of USA and an uncommon cause of pneumonia in non-endemic areas. We report a young Hispanic man who lives in New York presenting with diabetic ketoacidosis and severe pulmonary Coccidioidomycosis. Through this case report and review we want to familiarize clinicians from non-endemic area to this unusual cause for necrotizing pneumonia, its association with diabetes mellitus, other risk factors for dissemination and the management strategy. Introduction Pulmonary Coccidioidomycosis is an uncommon cause of necrotizing pneumonia in non-endemic areas. We report a case of severe pulmonary Coccidioidomycosis in a young immigrant who lives in New York and discuss the association with diabetes mellitus. Hospital Course A young 32 year old Hispanic man presented with 4-weeks history of polyuria, polyphagia and weight loss and 2-weeks history Figure 1: Chest radiograph showing right upper lobe consolidation and of hemoptysis and shortness of breath. He denied fever, chills, night retraction of horizntal fissure. sweats, sick contacts, skin rash, glandular swelling or recent travel.
    [Show full text]
  • Pharmacovigilance - Post
    PHARMACOVIGILANCE - POST MARKETING SURVEILLANCE NEWS Vol. 7 No. 3: Third Quarter Newsletter 2014 Editor’s Note I wish to thank all our numerous stakeholders who have been working tirelessly with the National Pharmacovigilance Centre (NPC) to ensure the safe use of medicines in Nigeria. The NPC is committed to sending quarterly newsletter to its stakeholders. The objectives of the Newsletter are to disseminate information on pharmacovigilance activities nationally and globally, to educate stakeholders on medicine safety issues, to promote rational use of drugs and to promote spontaneous reporting. This third quarter Newsletter focuses on Pharmacovigilance of Antidiabetic Drugs. We encourage all Health Care Professionals, Marketing Authorization Holders and other stakeholders to continue to report all adverse drug reactions. Your valued comments and acknowledgement of receipt of this issue through our email addresses ([email protected]; pharmacovigilance@nafdac,gov.ng ) would be most appreciated. Pharm. (Mrs.) Osakwe Director/NationalCoordinator, National Pharmacovigilance Centre (NPC) National Agency for Food and Drug Administration and Control (NAFDAC) Plot 2032 Olusegun Obasanjo Way Wuse Zone 7 Abuja PMB 5032 Wuse Abuja. Telephone 07098211221, 08086899571 E-mail: [email protected]; [email protected]; [email protected]; Website :www.nafdac.gov.ng Text any DRUG RELATED PROBLEM to SHORT CODE 20543 (for free on MTN, GLO and Etisalat) for action by the Pharmacovigilance Centre 1 PHARMACOVIGILANCE OF ANTIDIABETIC DRUGS Diabetes is one of the major causes of illnesses and deaths globally, and it affects many regardless of age or race. This disease can contribute to other health complications such as heart disease, kidney disease and blindness if not properly treated.
    [Show full text]
  • The Basics of Pharmacology
    THE BASICS OF PHARMACOLOGY Endocrine, Musculoskeletal, Genitourinary, Ear And Eye Systems Jassin M. Jouria, MD Dr. Jassin M. Jouria is a practicing Emergency Medicine physician, professor of academic medicine, and medical author. He graduated from Ross University School of Medicine and has completed his clinical clerkship training in various teaching hospitals throughout New York, including King’s County Hospital Center and Brookdale Medical Center, among others. Dr. Jouria has passed all USMLE medical board exams, and has served as a test prep tutor and instructor for Kaplan. He has developed several medical courses and curricula for a variety of educational institutions. Dr. Jouria has also served on multiple levels in the academic field including faculty member and Department Chair. Dr. Jouria continues to serve as a Subject Matter Expert for several continuing education organizations covering multiple basic medical sciences. He has also developed several continuing medical education courses covering various topics in clinical medicine. Recently, Dr. Jouria has been contracted by the University of Miami/Jackson Memorial Hospital’s Department of Surgery to develop an e- module training series for trauma patient management. Dr. Jouria is currently authoring an academic textbook on Human Anatomy & Physiology. ABSTRACT The science of pharmacology and the responsibility relationship building with patients are important elements of a health professional’s clinical knowledge and skills to provide safe and appropriate pharmacotherapeutic regimens in everyday practice. Interdisciplinary members of the health team are required to continually interpret specific patient health data to implement and evaluate outcomes of medication treatment. All health clinicians are increasingly relying on practice guidelines and the applied specialized training of health team members when obtaining the patient health history to improve therapeutic medication regimens, avoid adverse effects, and to safely and effectively treat a disease state.
    [Show full text]
  • Partial Target Organ Resistance to Thyroid Hormone
    Partial Target Organ Resistance to Thyroid Hormone Hans Henning Bode, … , Farahe Maloof, John D. Crawford J Clin Invest. 1973;52(4):776-782. https://doi.org/10.1172/JCI107240. Research Article An 8-year old boy with a small goiter, normal basal metabolic rate (BMR), and elevated serum thyroid hormone levels (thyroxine [T4] 19.5 μg per 100 ml, free T4 4 ng per 100 ml, triiodothyronine [T3] 505 ng per 100 ml) was studied. He had measurable serum thyroid-stimulating hormone (TSH) levels (average 5.5 μU per ml), and the thyroxine-binding proteins, hearing, and epiphyseal structures were normal. There was no parental consanguinity nor were there thyroid abnormalities either in the parents or six siblings. Methimazole, 50 mg daily, depressed thyroxine synthesis (T4 10.5, free T4 2.5) and caused a rise in TSH to 11 μU per ml. After discontinuation of treatment, TSH declined to 4.2 μU per ml and chemical hyperthyroidism returned (T4 21.0 μg per 100 ml, free T4 4.2, and total T3 475 ng per 100 ml, radioactive iodine [RAI] uptake 68%), but studies of BMR and insensible water loss showed the patient to be clinically euthyroid. Thyrotropin-releasing hormone (TRH), 200 μg i.v., caused a brisk rise in TSH to 28 μU per ml, with T4 rising to 28 μg per 100 ml, free T4 to 5.6, and T3 to 730 ng per 100 ml, thus indicating that the pituitary-thyroid system was intact and that the patient's TSH was biologically active. The unusual sensitivity of the pituitary cells to TRH […] Find the latest version: https://jci.me/107240/pdf Partial Target Organ Resistance to Thyroid Hormone HANS HENNING BODE, MARco DANON, BRUCE D.
    [Show full text]
  • History & Physical Format
    History & Physical Format SUBJECTIVE (History) Identification name, address, tel.#, DOB, informant, referring provider CC (chief complaint) list of symptoms & duration. reason for seeking care HPI (history of present illness) - PQRST Provocative/palliative - precipitating/relieving Quality/quantity - character Region - location/radiation Severity - constant/intermittent Timing - onset/frequency/duration PMH (past medical /surgical history) general health, weight loss, hepatitis, rheumatic fever, mono, flu, arthritis, Ca, gout, asthma/COPD, pneumonia, thyroid dx, blood dyscrasias, ASCVD, HTN, UTIs, DM, seizures, operations, injuries, PUD/GERD, hospitalizations, psych hx Allergies Meds (Rx & OTC) SH (social history) birthplace, residence, education, occupation, marital status, ETOH, smoking, drugs, etc., sexual activity - MEN, WOMEN or BOTH CAGE Review Ever Feel Need to CUT DOWN Ever Felt ANNOYED by criticism of drinking Ever Had GUILTY Feelings Ever Taken Morning EYE OPENER FH (family history) age & cause of death of relatives' family diseases (CAD, CA, DM, psych) SUBJECTIVE (Review of Systems) skin, hair, nails - lesions, rashes, pruritis, changes in moles; change in distribution; lymph nodes - enlargement, pain bones , joints muscles - fractures, pain, stiffness, weakness, atrophy blood - anemia, bruising head - H/A, trauma, vertigo, syncope, seizures, memory eyes- visual loss, diplopia, trauma, inflammation glasses ears - deafness, tinnitis, discharge, pain nose - discharge, obstruction, epistaxis mouth - sores, gingival bleeding, teeth,
    [Show full text]
  • Ocimum Gratissimum, Diabetes Mellitus, Polyphagia, Polydipsia, Weight Loss
    American Journal of Medicine and Medical Sciences 2012, 2(3): 45-49 DOI: 10.5923/j.ajmms.20120203.04 Oral Administration of Aqueous Leaf Extract of Ocimum Gratissimum Ameliorates Polyphagia, Polydipsia and Weight Loss in Streptozotocin-Induced Diabetic Rats OKON U. A.1,*, Owo D.U.3, Udokang N.E.1, Udobang J.A.2, Ekpenyong C.E.1 1Department of Physiology, College of Health Sciences, University of Uyo, Nigeria 2Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Uyo, Nigeria 3Department of Physiology, College of Medical Sciences, University of Calabar, Nigeria Abstract The effects of oral administration of aqueous leaf extract of Ocimum gratissimum (OG) on food, water intake and weight changes in streptozotocin (STZ)-induced diabetic Albino Wistar rats was studied. Eighteen rats were randomly assigned into 3 groups of 6 rats each for control, diabetic (DM) and diabetic-treated (DMT) groups. Diabetes mellitus was induced in the test groups (DM and DMT) by a single dose of STZ (65 mg/kg, i.p.). The extract was administered per oral to the DMT group at a dose of 1500 mg/k body weight daily for 28 days. All the groups were fed normal rat chow and al- lowed water freely. The fasting blood glucose levels in the DM and DMT groups were higher (P<0.001) than the control group, with the DMT group lower (P<0.01) than the DM group. There was a significant (P<0.05) loss of body weight in the DM group compared to the control (P<0.01) and DMT (P<0.05) groups.
    [Show full text]
  • Issues in Endocrinology
    VetEdPlus E-BOOK RESOURCES Issues in Endocrinology WHAT’S INSIDE The Diagnosis of Canine Hyperadrenocorticism Canine Hypothyroidism Feline Diabetes Mellitus Hypoadrenocorticism: Diagnosis and Treatment of Addison’s Disease Treatment of Pituitary-dependent A SUPPLEMENT TO Made possible by Hyperadrenocorticism an educational grant: Canine Diabetes Mellitus Chronic Pancreatitis in Felines E-BOOK PEER REVIEWED The Diagnosis of Canine Hyperadrenocorticism Audrey Cook, BVM&S, MSc VetEd, MRCVS, DACVIM-SAIM, DECVIM-CA, DABVP (Feline) Department of Small Animal Clinical Sciences, Texas A&M College of Veterinary Medicine and Biomedical Sciences College Station, Texas Hyperadrenocorticism (HAC or Cushing’s syndrome must have some (usually many) of the syndrome) describes the clinical manifestations classic signs (BOX 1). of chronic exposure to excessive glucocorticoids. Spontaneous HAC is often caused by More than 95% of dogs are polyuric/polydipsic; inappropriate secretion of adrenocorticotropic a normal water intake makes HAC less likely. hormone (ACTH) by a pituitary tumor (i.e., Additionally, most manifest dermatologic pituitary-dependent HAC [PDH]) or may reflect changes;2 in my experience, a good hair coat the autonomous production of cortisol by an adrenal tumor (AT).1 There are occasional reports of dogs with HAC BOX 1 Clinical Signs Commonly due to an aberrant response to a digestive hormone Associated With Canine HAC (i.e., food-dependent HAC) or from ectopic Polyuria and polydipsia ACTH secretion, but these are extremely rare. Polyphagia Panting CLINICAL PRESENTATION Abdominal distention Spontaneous HAC is usually diagnosed in older Hepatomegaly dogs, particularly Boston terriers, dachshunds, Muscle weakness 1 miniature poodles, and beagles. It is uncommon Dermatologic changes in dogs younger than 5 years of age.
    [Show full text]
  • Symptom and Mode of Presentation of Diabetes Mellitus Type 2 in Patients of Ajmer City
    International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Symptom and Mode of Presentation of Diabetes Mellitus Type 2 in Patients of Ajmer City Laxmi Kumari Yadav1, Dr Bharti Prakash2 1Assistant Professor, Department of Zoology, S.P.C. Government College Ajmer. 2Associate Professor, Department of Zoology, S.P.C. Government College Ajmer. Corresponding Author: Laxmi Kumari Yadav ABSTRACT Diabetes mellitus type 2 is a major lifestyle disease and the most challenging public health problem of 21st century. It is the major causes of morbidity and mortality affecting the youth and middle aged people. Aim: This study aim to find out the most common symptoms and mode of presentation of diabetes accruing in the people of Ajmer on the onset of diabetes type 2. Method: A detailed questionnaire was precisely phrased for obtaining the desired information‟s on symptom, mode of presentation, complications and other general information. Analysis: Data were tabulated on Microsoft excel and analyzed using frequencies and percentages. Result: the mean age of diagnosis of diabetes was 54.45 ± 13.16 years. Majority 23% (109) out of 464 patient‟s comprised male 25% (63) and female 22% (46) felt fatigue and weakness as a symptom for diabetes and polyuria, polydipsia, polydipsia were the most common presenting symptoms faced by 19% (88) of patients. In 24% of the patients diabetes was diagnosed “by chance” during their general checkup in hospital and 16% were identified incidentally at the time of surgery in body part. Conclusion: it was concluded that diagnosed as diabetes on the first time, at routine screening of patients and more common symptoms are fatigue, weakness, polydipsia, polyphagia and polyurea.
    [Show full text]
  • Diabetic Emergencies Vs. Alcohol Intoxication GFR Training November 13, 2016 What Is Diabetes?
    Diabetic Emergencies vs. Alcohol Intoxication GFR Training November 13, 2016 What is Diabetes? Diabetes is a metabolic disease in which the body’s inability to produce sufficient insulin or use insulin properly causes elevated levels of glucose in the blood Insulin: hormone that helps glucose move out of the bloodstream, across cell membranes, and into the cell where it is used for metabolism What is Diabetes? Type 1 – Juvenile Diabetes ◦ Pancreas is unable to produce sufficient insulin, if any at all. ◦ Results in hyperglycemia ◦ Most common in Caucasians Type 2 – Adult-onset Diabetes ◦ Body doesn’t utilize insulin properly. Cells become resistant to the effects of insulin, decreasing the efficiency of glucose passing through the cell membrane (aka insulin resistance). ◦ At first, the body makes excess insulin to make up for it, but over time it can’t keep up and eventually BG rises. ◦ More common than type 1 Hyperglycemia If insulin is low, BG begins to rise, causing hyperglycemia (high BG). However, due to the lack of insulin, the body’s cells will not receive enough glucose. In absence of glucose, the cells will begin to use stored fats and proteins for energy metabolism, which is not as efficient as using glucose Glucose metabolism produces water and CO2 Fat metabolism produces ketone bodies, such as acetone, which can increase the acidity of the blood • This is called diabetic ketoacidosis (DKA) Diabetic Ketoacidosis (DKA) Life threatening complication More common in Type 1 Diabetes Signs and symptoms may manifest gradually
    [Show full text]